Article Menu
-
Academic Editor
Daruka Mahadevan
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Mauro, F. Romana
- Paoloni, F.
- Molica, S.
- Reda, G.
- Trentin, L.
- Sportoletti, P.
- Marchetti, M.
- Pietrasanta, D.
- Marasca, R.
- Gaidano, G.
- Coscia, M.
- Stelitano, C.
- Mannina, D.
- Di Renzo, N.
- Ilariucci, F.
- Liberati, A. Marina
- Orsucci, L.
- Re, F.
- Tani, M.
- Musuraca, G.
- Gottardi, D.
- Zinzani, P. Luigi
- Gozzetti, A.
- Molinari, A.
- Gentile, M.
- Chiarenza, A.
- Laurenti, L.
- Varettoni, M.
- Ibatici, A.
- Murru, R.
- Ruocco, V.
- Del Giudice, I.
- De Propris, M. Stefania
- Della Starza, I.
- Raponi, S.
- Nanni, M.
- Fazi, P.
- Neri, A.
- Guarini, A.
- Rigolin, G. Matteo
- Piciocchi, A.
- Cuneo, A.
- Foà , R.
- on Google Scholar
- Mauro, F. Romana
- Paoloni, F.
- Molica, S.
- Reda, G.
- Trentin, L.
- Sportoletti, P.
- Marchetti, M.
- Pietrasanta, D.
- Marasca, R.
- Gaidano, G.
- Coscia, M.
- Stelitano, C.
- Mannina, D.
- Di Renzo, N.
- Ilariucci, F.
- Liberati, A. Marina
- Orsucci, L.
- Re, F.
- Tani, M.
- Musuraca, G.
- Gottardi, D.
- Zinzani, P. Luigi
- Gozzetti, A.
- Molinari, A.
- Gentile, M.
- Chiarenza, A.
- Laurenti, L.
- Varettoni, M.
- Ibatici, A.
- Murru, R.
- Ruocco, V.
- Del Giudice, I.
- De Propris, M. Stefania
- Della Starza, I.
- Raponi, S.
- Nanni, M.
- Fazi, P.
- Neri, A.
- Guarini, A.
- Rigolin, G. Matteo
- Piciocchi, A.
- Cuneo, A.
- Foà , R.
- on PubMed
- Mauro, F. Romana
- Paoloni, F.
- Molica, S.
- Reda, G.
- Trentin, L.
- Sportoletti, P.
- Marchetti, M.
- Pietrasanta, D.
- Marasca, R.
- Gaidano, G.
- Coscia, M.
- Stelitano, C.
- Mannina, D.
- Di Renzo, N.
- Ilariucci, F.
- Liberati, A. Marina
- Orsucci, L.
- Re, F.
- Tani, M.
- Musuraca, G.
- Gottardi, D.
- Zinzani, P. Luigi
- Gozzetti, A.
- Molinari, A.
- Gentile, M.
- Chiarenza, A.
- Laurenti, L.
- Varettoni, M.
- Ibatici, A.
- Murru, R.
- Ruocco, V.
- Del Giudice, I.
- De Propris, M. Stefania
- Della Starza, I.
- Raponi, S.
- Nanni, M.
- Fazi, P.
- Neri, A.
- Guarini, A.
- Rigolin, G. Matteo
- Piciocchi, A.
- Cuneo, A.
- Foà , R.
Need Help?
Order Article Reprints
Journal: Cancers, 2022
Volume: 14
Number: 207
207
Article:
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study
Authors:
by
Francesca Romana Mauro, Francesca Paoloni, Stefano Molica, Gianluigi Reda, Livio Trentin, Paolo Sportoletti, Monia Marchetti, Daniela Pietrasanta, Roberto Marasca, Gianluca Gaidano, Marta Coscia, Caterina Stelitano, Donato Mannina, Nicola Di Renzo, Fiorella Ilariucci, Anna Marina Liberati, Lorella Orsucci, Francesca Re, Monica Tani, Gerardo Musuraca, Daniela Gottardi, Pier Luigi Zinzani, Alessandro Gozzetti, Annalia Molinari, Massimo Gentile, Annalisa Chiarenza, Luca Laurenti, Marzia Varettoni, Adalberto Ibatici, Roberta Murru, Valeria Ruocco, Ilaria Del Giudice, Maria Stefania De Propris, Irene Della Starza, Sara Raponi, Mauro Nanni, Paola Fazi, Antonino Neri, Anna Guarini, Gian Matteo Rigolin, Alfonso Piciocchi, Antonio Cuneo and Robin Foà add
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/14/1/207
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Mauro, F.R.; Paoloni, F.; Molica, S.; Reda, G.; Trentin, L.; Sportoletti, P.; Marchetti, M.; Pietrasanta, D.; Marasca, R.; Gaidano, G.; et al. Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. Cancers 2022, 14, 207. https://doi.org/10.3390/cancers14010207
Mauro FR, Paoloni F, Molica S, Reda G, Trentin L, Sportoletti P, Marchetti M, Pietrasanta D, Marasca R, Gaidano G, et al. Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. Cancers. 2022; 14(1):207. https://doi.org/10.3390/cancers14010207
Chicago/Turabian StyleMauro, Francesca Romana, Francesca Paoloni, Stefano Molica, Gianluigi Reda, Livio Trentin, Paolo Sportoletti, Monia Marchetti, Daniela Pietrasanta, Roberto Marasca, Gianluca Gaidano, and et al. 2022. "Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study" Cancers 14, no. 1: 207. https://doi.org/10.3390/cancers14010207
APA StyleMauro, F. R., Paoloni, F., Molica, S., Reda, G., Trentin, L., Sportoletti, P., Marchetti, M., Pietrasanta, D., Marasca, R., Gaidano, G., Coscia, M., Stelitano, C., Mannina, D., Di Renzo, N., Ilariucci, F., Liberati, A. M., Orsucci, L., Re, F., Tani, M., ... Foà , R. (2022). Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. Cancers, 14(1), 207. https://doi.org/10.3390/cancers14010207
